Previous 10 | Next 10 |
Summary There is one notable trade that is not a buy this month as I decided to shuttle Warner Bros. Discovery, Inc. Today, it seems that every company is engaged in accounting trickery fooling shareholders with crap spin-offs that only disguise real dividend cuts. I continue ...
Summary A high level of restructuring is occurring with the Healthcare industry’s largest constituents. Most restructuring is taking the form of splits or spin-offs, but not all incidences look beneficial. This article will summarize coming transactions and provide comm...
Viatris Inc. (VTRS) BofA Global Research Global Healthcare Conference September 15, 2022 11:45 AM ET Company Participants Michael Goettler – Chief Executive Officer Rajiv Malik – President Sanjeev Narula – Chief Financial Officer Confer...
Pharmaceutical businesses spend billions of dollars developing medicines that they then protect with a fortress of intellectual property (IP) safeguards to make sure that competitors can't benefit from their work. But for companies with a bit of patience, it pays to wait out the years o...
Summary With all the recent market volatility, there is no shortage of stocks that are looking seemingly cheaper when compared to the closing months of 2021. First up, I’m thinking about adding to the recent spin-off Viatris Inc. Finally, I am looking at Verizon Communi...
Viatris Inc. to Participate in BofA Global Research Global Healthcare Conference PR Newswire PITTSBURGH , Sept. 6, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global pharmaceutical company, today announced the company will participate in the B...
Summary Viatris's total revenue was $4,116.8 million in Q2 2022, down 10.1% year-on-year. Sales of the company's branded medicines have been declining since the formation of Viatris in 2020. The company has a dividend yield of 5.08%, but dividend payouts are at risk from 2026....
Summary Davis Selected Advisers' 13F portfolio value decreased from $19.79B to $15.59B this quarter. They increased Teck Resources and Owens Corning while reducing Alibaba Group Holding and American Express. The top three positions are Wells Fargo, Berkshire Hathaway, and Capi...
Summary The stock market took a nose dive on August 26th, shedding over 3% in some instances on the overall valuation of the stock market. Diageo yields well above the S&P 500 and is a better yield on average than the majority of high quality stocks. The yield for Viatris ...
Heading into the last three months of the year, there is no shortage of quality stocks for income investors to choose from now. Three of the best ones you can buy today include Viatris (NASDAQ: VTRS) , Chevron (NYSE: CVX) , and AT&T (NYSE: T) . They all pay bette...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...